One Genomics
Curated by SignalProvider of genome editing technology for therapeutic applications
Overview
Provider of genome editing technology for therapeutic applications. The company has a proprietary platform known as Safeguard focuses on enhancing the precision, efficacy, and safety of CRISPR gene editing, which is crucial for developing therapies for genetic diseases, cancer, and longevity.
Key facts
- Founded
- 2023
- Headquarters
- San Francisco, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view